Fathema Uddin
Impact in
Papers in
- Oncology 4
- Lung Cancer Research Studies 3
- Co-authors
- Charles M. RudinTriparna SenNisargbhai ShahElisa de StanchinaÀlvaro Quintanal-VillalongaBenelita T. ElieMarı́a ContelOmar Hayatt
- Journals
- Cell Reports (2 papers)JBIC Journal of Biological Inorganic Chemistry (1 paper)Frontiers in Oncology (1 paper)Journal of Thoracic Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Fathema Uddin
7 papers receiving 715 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Business and International Management 30
- Aging 16
- Oncology 224
- Cancer Research 120
- Molecular Biology 498
Countries citing papers authored by Fathema Uddin
This map shows the geographic impact of Fathema Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fathema Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fathema Uddin more than expected).
Fields of papers citing papers by Fathema Uddin
This network shows the impact of papers produced by Fathema Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fathema Uddin. The network helps show where Fathema Uddin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fathema Uddin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 81 | |
| 2 | 2022 | 78 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 158 | |
| 6 | CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future Hit paper breakdown → | 2020 | 354 |
| 7 | 2018 | 53 |
About Fathema Uddin
Fathema Uddin is a scholar working on Business and International Management, Oncology, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 7 papers that have together received 727 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), RNA modifications and cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer therapeutics and mechanisms (1 paper), Click Chemistry and Applications (1 paper), Virus-based gene therapy research (1 paper), Single-cell and spatial transcriptomics (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Business and International Management (30 citations), Aging (16 citations), Oncology (224 citations), Cancer Research (120 citations) and Molecular Biology (498 citations). Fathema Uddin has collaborated with scholars based in United States and Japan. Frequent co-authors include Charles M. Rudin, Triparna Sen, Nisargbhai Shah, Elisa de Stanchina, Àlvaro Quintanal-Villalonga, Benelita T. Elie, Marı́a Contel, Omar Hayatt, Corrin A. Wohlhieter and John T. Poirier. Their work appears in journals such as Cell Reports, JBIC Journal of Biological Inorganic Chemistry, Frontiers in Oncology, Journal of Thoracic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.